Here, we aimed to systematically dissect the frequency of genetic alterations in SWI/SNF subunit genes other than ARID1A that might contribute to inactivation of SWI/SNF complexes in urothelial bladder carcinomas. This evidence concerns the gene SMARCA1 and bladder transitional cell carcinoma.